Overactive bladder in special patient populations

Area of Science:

• Urology
• Pharmacology
• Patient Care

Background:

• Overactive bladder (OAB) significantly impairs quality of life for many individuals.
• Antimuscarinic agents are the primary pharmacological treatment for OAB.
• Concerns exist regarding the safety and efficacy of antimuscarinics in specific patient demographics.

Purpose of the Study:

• To review the use of antimuscarinic agents in specific OAB patient populations.
• To discuss current knowledge on antimuscarinic therapy in pediatric, geriatric, pregnant, men with prostate issues, and neurogenic OAB patients.

Main Methods:

• Literature review of existing studies and clinical guidelines.
• Analysis of adverse events and side effect profiles in distinct patient groups.
• Synthesis of current understanding regarding antimuscarinic use in vulnerable populations.

Main Results:

• Antimuscarinic use is limited in certain OAB populations due to potential adverse events.
• Specific concerns include pediatric, geriatric, pregnant, and neurogenic OAB patients.
• Data on efficacy and safety in these groups are still evolving.

Conclusions:

• Physicians must carefully weigh the benefits and risks of antimuscarinics in specific OAB patient groups.
• Further research is needed to optimize antimuscarinic therapy for pediatric, geriatric, pregnant, and neurogenic OAB.
• Individualized treatment approaches are crucial for managing OAB in diverse patient populations.